Commodore Capital’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.8M | Hold |
1,988,084
| – | – | 2.1% | 19 |
|
|
2025
Q1 | $32.1M | Hold |
1,988,084
| – | – | 2.36% | 16 |
|
|
2024
Q4 | $46.3M | Hold |
1,988,084
| – | – | 3.39% | 11 |
|
|
2024
Q3 | $58.5M | Hold |
1,988,084
| – | – | 3.65% | 10 |
|
|
2024
Q2 | $46.7M | Buy |
1,988,084
+104,000
| +6% | +$2.45M | 3.19% | 13 |
|
|
2024
Q1 | $71.5M | Hold |
1,884,084
| – | – | 4.78% | 5 |
|
|
2023
Q4 | $40.5M | Buy |
1,884,084
+1,767,760
| +1,520% | +$38M | 3.54% | 11 |
|
|
2023
Q3 | $1.42M | Hold |
116,324
| – | – | 0.17% | 29 |
|
|
2023
Q2 | $1.31M | Buy |
+116,324
| New | +$1.31M | 0.15% | 25 |
|